loader

novavax inc

LATEST ARTICLES

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Novavax to Participate in Upcoming Investor Conferences

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Novavax Announces Entering into a License Agreement with Pfizer

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Novavax to Participate in Jefferies London Healthcare Conference

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid, Triggering a $25 Million Milestone Payment

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES